F. Schaper

Most-cited papers

1. High mobility group box 1 skews macrophage polarization and negatively influences phagocytosis of apoptotic cells.

   F. Schaper, K. de Leeuw, G. Horst, H. Bootsma +4 more

   2016Rheumatology73 citations Open access

   Semantic Scholar

   Save

2. Recent Developments in the Role of High-Mobility Group Box 1 in Systemic Lupus Erythematosus

   F. Schaper, J. Westra, M. Bijl

   2014Molecular Medicine53 citations Open access

   Semantic Scholar

   Save

3. Antitumor Immunity Is Controlled by Tetraspanin Proteins

   F. Schaper, A. V. van Spriel

   2018Frontiers in Immunology40 citations Open access

   Semantic Scholar

   Save

4. Tetraspanin CD53 controls T cell immunity through regulation of CD45RO stability, mobility, and function.

   V. E. Dunlock, Abbey B. Arp, S. Singh, Stéphanie Charrin +13 more

   2022Cell Reports29 citations Open access

   Semantic Scholar

   Save

5. Treatment with Anti-HMGB1 Monoclonal Antibody Does Not Affect Lupus Nephritis in MRL/lpr Mice

   F. Schaper, M. V. van Timmeren, A. Petersen, G. Horst +4 more

   2016Molecular Medicine19 citations Open access

   Semantic Scholar

   Save

6. Inhibition of high-mobility group box 1 as therapeutic option in autoimmune disease: lessons from animal models

   F. Schaper, P. Heeringa, M. Bijl, J. Westra

   2013Current Opinion in Rheumatology19 citations

   Semantic Scholar

   Save

7. Enhancing Patient Understanding of Laboratory Test Results: Systematic Review of Presentation Formats and Their Impact on Perception, Decision, Action, and Memory

   Frederieke A. M. van der Mee, F. Schaper, J. Jansen, J. Bons +2 more

   2023Journal of Medical Internet Research17 citations Open access

   Semantic Scholar

   Save

8. Lack of IL-17 Receptor A signaling aggravates lymphoproliferation in C57BL/6 lpr mice

   O. Corneth, F. Schaper, F. Luk, P. Asmawidjaja +6 more

   2019Scientific Reports15 citations Open access

   Semantic Scholar

   Save

9. Autoantibodies to box A of high mobility group box 1 in systemic lupus erythematosus

   F. Schaper, K. de Leeuw, G. Horst, F. Maas +4 more

   2017Clinical and Experimental Immunology15 citations Open access

   Semantic Scholar

   Save

10. Treatment with anti-HMGB 1 monoclonal antibody does not affect lupus nephritis in MRL / lpr mice

    F. Schaper, MM van Timmeren, A. Petersen, G. Horst +4 more

    20162 citations

    Semantic Scholar

    Save

11. University of Groningen Recent Developments in the Role of High-Mobility Group Box 1 in Systemic Lupus

    F. Schaper, J. Westra, M. Bijl

    20181 citations

    Semantic Scholar

    Save

12. Involvement of high mobility group box 1 in the auto-inflammatory process in systemic lupus erythematosus

    F. Schaper

    20160 citations

    Semantic Scholar

    Save

13. Involvement of high mobility group box 1 in the auto-inflammatory process in systemic lupus erythematosus

    F. Schaper, J. Westra, M. Bijl

    20160 citations

    Semantic Scholar

    Save

14. University of Groningen Treatment with Anti-HMGB1 Monoclonal Antibody Does Not Affect Lupus Nephritis in MRL/lpr Mice

    F. Schaper, M. V. van Timmeren, A. Petersen, G. Horst +4 more

    20160 citations

    Semantic Scholar

    Save

15. Autoantibodies to high mobility group box 1 in patients with Incomplete and Systemic Lupus Erythematosus

    F. Schaper, K. de Leeuw, G. Horst, F. Maas +5 more

    20150 citations

    Semantic Scholar

    Save